Predictors of Response for “Off” Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA Registry

Background: Levodopa-carbidopa intestinal gel (LCIG) is a long-term therapy for motor fluctuations in patients with advanced Parkinson's disease (PD). The aim of this analysis was to identify the baseline characteristics that predict “Off” time reduction in advanced PD patients treated with LCI...

Descripción completa

Detalles Bibliográficos
Autores principales: Poewe, Werner, Bergmann, Lars, Robieson, Weining Z., Antonini, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318911/
https://www.ncbi.nlm.nih.gov/pubmed/32636792
http://dx.doi.org/10.3389/fneur.2020.00419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318911/
https://www.ncbi.nlm.nih.gov/pubmed/32636792
http://dx.doi.org/10.3389/fneur.2020.00419

Ejemplares similares